Insider Trading Alert - TASR, ATHX And GEO Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 10, 2015, 92 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $6.99 to $188,811,000.00.

Highlighted Stocks Traded by Insiders:

Taser International (TASR) - FREE Research Report

Womack Marcus, who is General Manager, EVIDENCE.com at Taser International, sold 25,000 shares at $34.64 on June 10, 2015. Following this transaction, the General Manager, EVIDENCE.com owned 53,162 shares meaning that the stake was reduced by 31.98% with the 25,000-share transaction.

The shares most recently traded at $34.61, down $0.03, or 0.09% since the insider transaction. Historical insider transactions for Taser International go as follows:

  • 4-Week # shares sold: 1,035
  • 12-Week # shares bought: 50,000
  • 12-Week # shares sold: 187,922
  • 24-Week # shares bought: 50,000
  • 24-Week # shares sold: 201,788

The average volume for Taser International has been 2.4 million shares per day over the past 30 days. Taser International has a market cap of $1.8 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are up 32.02% year-to-date as of the close of trading on Wednesday.

TASER International, Inc. develops, manufactures, and sells conducted electrical weapons (CEWs) worldwide. It operates through two segments, TASER Weapons and AXON. The company has a P/E ratio of 76.3. Currently, there are 2 analysts who rate Taser International a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TASR - FREE

TheStreet Quant Ratings rates Taser International as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Taser International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Athersys (ATHX) - FREE Research Report

Traub Kenneth H, who is Director at Athersys, bought 30,000 shares at $1.27 on June 10, 2015. Following this transaction, the Director owned 80,000 shares meaning that the stake was boosted by 60% with the 30,000-share transaction.

The shares most recently traded at $1.28, up $0.01, or 0.78% since the insider transaction. Historical insider transactions for Athersys go as follows:

  • 4-Week # shares bought: 30,000
  • 4-Week # shares sold: 25,000
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 25,000
  • 24-Week # shares bought: 30,000
  • 24-Week # shares sold: 47,730

The average volume for Athersys has been 2.0 million shares per day over the past 30 days. Athersys has a market cap of $104.4 million and is part of the health care sector and drugs industry. Shares are down 22.78% year-to-date as of the close of trading on Wednesday.

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Currently, there are 3 analysts who rate Athersys a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ATHX - FREE

TheStreet Quant Ratings rates Athersys as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Athersys Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

GEO Group (GEO) - FREE Research Report

Carlson Norman A, who is Director at GEO Group, sold 12,138 shares at $36.43 on June 10, 2015. Following this transaction, the Director owned 34,894 shares meaning that the stake was reduced by 25.81% with the 12,138-share transaction.

The shares most recently traded at $35.71, down $0.72, or 2.01% since the insider transaction. Historical insider transactions for GEO Group go as follows:

  • 4-Week # shares bought: 100,000
  • 4-Week # shares sold: 625
  • 12-Week # shares bought: 100,000
  • 12-Week # shares sold: 625
  • 24-Week # shares bought: 100,000
  • 24-Week # shares sold: 15,340

The average volume for GEO Group has been 556,500 shares per day over the past 30 days. GEO Group has a market cap of $2.7 billion and is part of the financial sector and real estate industry. Shares are down 11.03% year-to-date as of the close of trading on Wednesday.

The GEO Group, Inc. provides government-outsourced services specializing in the management of correctional, detention, and re-entry facilities, and the provision of community based services and youth services in the United States, Australia, South Africa, the United Kingdom, and Canada. The stock currently has a dividend yield of 6.92%. The company has a P/E ratio of 18.1. Currently, there are 5 analysts who rate GEO Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GEO - FREE

TheStreet Quant Ratings rates GEO Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, increase in net income, notable return on equity and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full GEO Group Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Dow Falls, S&P 500 Trades Lower as P&G and Apple Slump

Dow Falls, S&P 500 Trades Lower as P&G and Apple Slump

Video: Jim Cramer on Apple, Procter & Gamble, Nucor and Acacia Communications

Video: Jim Cramer on Apple, Procter & Gamble, Nucor and Acacia Communications

Video: Jim Cramer Reveals Why Stocks Are Moving Lower Thursday

Video: Jim Cramer Reveals Why Stocks Are Moving Lower Thursday

Soaring Nickel Prices Could Be Bad News for Electric Carmakers Like Tesla

Soaring Nickel Prices Could Be Bad News for Electric Carmakers Like Tesla

Video: The Road to S&P 500 2,800 Is 'Slow and Choppy'

Video: The Road to S&P 500 2,800 Is 'Slow and Choppy'